Validation of the 3D Skin Comet assay using full thickness skin models: transferability and reproducibility
Kerstin Reisinger
Frontiers in Genetics · 2015
doi:10.3389/conf.fgene.2015.01.00001 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
The 3D Skin Comet assay was developed to improve the in vitro prediction of the genotoxic potential of dermally applied chemicals. For this purpose, a classical read-out for genotoxicity (i.e. comet formation) was combined with reconstructed 3D skin models as well-established test systems. Five laboratories (BASF, BfR (Federal Institute for Risk Assessment), Henkel, Procter & Gamble and TNO Triskilion) started to validate this assay using the Phenion® Full- Thickness (FT) Skin Model and 8 coded chemicals with financial support by Cosmetics Europe and the German Ministry of Education & Research. There was an excellent overall predictivity of the expected genotoxicity (>90%). Four labs correctly identified all chemicals and the fifth correctly identified 80% of the chemicals. Background DNA damage was low and values for solvent (acetone) and positive (methyl methanesulfonate (MMS)) controls were comparable among labs. Inclusion of the DNA-polymerase inhibitor, aphidicolin (APC), in the protocol improved the predictivity of the assay since it enabled robust detection of pro-mutagens e.g., 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene. Therefore, all negative findings are now confirmed by additional APC experiments to come to a final conclusion. Furthermore, MMC, which intercalates between DNA strands causing covalent binding, was detected with the standard protocol, in which it gave weak but statistically significant responses. Stronger responses, however, were obtained using a cross-linker specific protocol in which MMC reduced the migration of MMS-induced DNA damage. These data support the use of the Phenion® FT in the Comet assay: no false-positives and only one false-negative finding in a single lab. Testing will continue to obtain data for 30 chemicals. Once validated, the 3D Skin Comet assay is foreseen to be used as a follow-up test for positive results from the current in vitro genotoxicity test battery.
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.